Clinical software systems can be installed, configured, and implemented in daily use without ever having gone through validation. 

This is the gap GCP auditing services are designed to find.  In clinical research, this becomes important. EDC, eTMF, CTMS, ePRO, safety databases, and electronic source systems all process data that may have an impact on trial operations, subject safety, and regulatory decisions. For CROs and BA/BE centers/sites that run trials for USFDA, EMA, or CDSCO submissions in India, the list includes LIMS and Chromatography data systems.

ICH E6(R3) (Source) expects computerized systems used in clinical trials to be validated using a risk-based approach that considers their intended use and potential impact on participant protection and the reliability of trial results. For FDA-regulated studies, 21 CFR Part 11 also establishes requirements for applicable electronic records and electronic signatures. This is where GCP auditing services go beyond checking whether a system is technically running. The real question is whether it is controlled, documented, secure, traceable, and suitable for the way it is actually used.

Installed Does Not Mean Validated

Installation confirms that the software is available and functioning. Validation asks a harder question: can the system consistently perform its intended function while protecting the reliability and integrity of trial data? An auditor therefore looks beyond “Does it work?” and asks:

  • Was the intended use clearly defined?
  • Were critical functions tested before go-live?
  • Were study-specific configurations verified?
  • Are system changes controlled?
  • Can data modifications be reconstructed?
  • Can records be retrieved when required?

What Do GCP Auditing Services Examine?

A typical audit of a clinical system will include the assessment of requirements, validation plan, risk analysis, test cases, test execution evidence, deviations, approvals, release records, and change control history. This is not an exercise for the sake of documents. Every document must provide evidence that the system has been audited, taking into account its purpose and its impact on the trial data.

For sponsors that consider different options for GCP audit services in India, one of the first questions to be answered is, “who validated what?” For hosted or SaaS systems, vendors may provide validation evidence for the core platform. Sponsors must assess whether that evidence, together with study-specific configurations, user access controls, and intended use, adequately supports the system’s use in their trials.  Auditors look for evidence that both layers were assessed, and that the boundary between them is written down.” 

Interfaces Are Where Data Gets Lost

GCP auditing services check whether interfaces were tested with realistic data, whether transfer failures are detected and logged, and whether reconciliation between systems is defined, performed and documented. A system can pass every internal test and still deliver incomplete data if its interfaces were never validated. 

Audit Trails and Access: Who Controls the Controls?

Auditors confirm that the audit trail captures who changed what, when, the previous value, and, where required, the reason. How sponsors should review those trails is covered in our guide to GCP regulatory requirements sponsors often miss. At system level, the sharper question is who can switch those controls off.

Auditors look at role design, segregation of duties, privileged administrator accounts and electronic signature controls. An administrator who can both edit trial data and change audit trail settings is a gap that stands out quickly, as are generic “admin” accounts that no single person owns.

Can You Still Retrieve the Data Years Later?

Trial records must remain available long after the last participant visit. Auditors check whether backups are taken and, more importantly, whether a restore has ever been tested. They also ask what happens when a vendor contract ends, or a system is retired: can the records, metadata and audit trails be exported in a readable, complete form?

What Happens After a Clinical System Changes?

Validation is not a one-time exercise. Systems are upgraded, configurations change, and modules are added mid-study. Auditors examine change controls, impact assessments, regression testing and approvals, along with evidence that affected functions still work as intended. Not every update needs the same depth of testing. The assessment should reflect the risk the change introduces.

The Real Test: Can You Defend the System?

A validation folder on a shelf does not make a system validated. The stronger test is whether you can show that the system remains fit for its intended clinical use, that its interfaces deliver complete data, that changes are controlled and that records stay secure, traceable and retrievable.

Pharmazone supports sponsors, CROs and BA/BE centers through GCP auditing services that include pre-inspection gap audits, CRO and site audits, vendor audits and monitoring across the clinical, bioanalytical and pharmacokinetic phases. As an Ahmedabad-based consultancy with region-based independent auditors, we can review systems where your sites, labs and vendors actually operate.

When an auditor asks how a critical clinical system was controlled, “it was installed and working” is only the beginning of the answer. To discuss a GCP system audit for your trial, contact our team.